Home > Insider Trading > Filing (0001144204-14-054303)

Filing Details

Accession Number:: 0001144204-14-054303
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-09-04 16:47:37
Reporting Period:: 2014-09-02

Filing Date:: 2014-09-04
Accepted Time:: 2014-09-04 16:47:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1232524	Jazz Pharmaceuticals Plc	JAZZ	Pharmaceutical Preparations (2834)	981032470

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253886	G Patrick Enright	C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2014-09-02	7,894	$162.71	384,248	No	4	S	Indirect	By Longitude Venture Partners, L.P.
Ordinary Shares	Disposition	2014-09-02	1,909	$163.89	382,339	No	4	S	Indirect	By Longitude Venture Partners, L.P.
Ordinary Shares	Disposition	2014-09-02	159	$162.71	7,699	No	4	S	Indirect	By Longitude Capital Associates, L.P.
Ordinary Shares	Disposition	2014-09-02	38	$163.88	7,661	No	4	S	Indirect	By Longitude Capital Associates, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Longitude Venture Partners, L.P.
No	4	S	Indirect	By Longitude Venture Partners, L.P.
No	4	S	Indirect	By Longitude Capital Associates, L.P.
No	4	S	Indirect	By Longitude Capital Associates, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	3,993	Direct

Footnotes

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $162.28 to $163.11. The price reported reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $163.40 to $164.35. The price reported reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $162.28 to $163.11. The price reported reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $163.40 to $164.35. The price reported reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P., except to the extent of his pecuniary interest therein.